Adani Ports breaks out at record Rs 1,747 as 500 MMT milestone meets Hormuz reroute trade (NSE: ADANIPORTS)
Read More Pharma Industry News How Novo Nordisk is building a post-semaglutide strategy: Inside its metabolic pipeline and innovation bets Novo Nordisk pivots beyond semaglutide with amycretin, CagriSema, and oral GLP-1 therapies. See how it’s building its next-generation obesity drug platform. byPallavi MadhirajuJune 24, 2025